Brighter enters into a share purchase agreement with Camanio Care on the acquisition of Camanio Care’s subsidiary.
Brighter AB (publ) ("Brighter") has on 8 September 2019 announced that it has signed a letter of intent with Camanio Care AB (publ) ("Camanio Care") regarding the acquisition of all shares in Camanio Care's subsidiary holding the complete business of Camanio Care. Brighter has today entered into a share purchase agreement with Camanio Care regarding the terms of the acquisition. The agreement stipulates that the purchase price for the subsidiary is 17 MSEK. The acquisition of Camanio Care's subsidiary also requires that the acquisition is approved by Camanio Care at an Extraordinary General Meeting.
The purchase price for the planned acquisition is intended to be paid by Brighter through a non-cash issue directed to Camanio Care, in which Camanio Care will transfer all shares in its subsidiary to Brighter as consideration for subscribed shares. The value of the number of shares planned to be issued by Brighter in the non-cash issue will correspond to the agreed purchase price for the subsidiary. This number of shares to be issued will be established on the basis of the volume-weighted average price for the Brighter share during a period of twenty (20) trading days before the decision on the non-cash issue.
If the general meeting in Camanio Care approves of the transfer of the subsidiary to Brighter, the transaction will be executed in accordance with the following preliminary time schedule.
|Preliminary time schedule||Time|
|Extraordinary general meeting in Camanio Care resolves to approve of the transfer of the shares in the subsidiary to Brighter||14 October, 2019|
|The period during which the subscription price in the non-cash issue is established||16 September - 11 October, 2019|
|The board of Brighter resolves on the non-cash issue||14 October, 2019|
For further information, please contact:
Henrik Norström, CEO
Phone: +46 733 40 30 45
Ann Zetterberg, CFO
Phone: +46 708 37 21 23
About Brighter AB (publ).
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare’s biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop®- is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/
The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 00, firstname.lastname@example.org, www.eminova.se.
This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 21:00 CET on September 29, 2019.